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patients (66%), AC: 43 patients (32%) and other carcinomas: 3 
patients (2%). Comparing the cohorts of the original and 
present study, patient characteristics were similar except for 
a significantly lower T- and N-stage in the present cohort.  
Tumor specimens were ranked for each of the 15 genes and 
the final rank was the median of the individual gene ranks. A 
low ranking correlated with a more hypoxic genotype and a 
high ranking with a less hypoxic genotype. In addition, a gene 
clustering analysis was performed. 
Results: Consistent with the original study, an unsupervised 
hierarchical clustering of the 15 genes showed inter-group 
heterogeneity between the ESCC and the AC group, and 
intra-group heterogeneity in the ESCC group. Also consistent 
with the original study, no intra-group variability was 
observed for patients with AC. Hence, the analysis suggested 
that hypoxia was more profound in ESCC.  
In contrast, the previous indication of a prognostic value of 
hypoxia in patients with ESCC was not reproducible when 
dividing patients according to ranking, divided by tertiles and 
grouping upper tertile versus mid plus lower tertile (Overall 
survival: HR: 1.01, P=0.98 (Fig. 1)); Disease-specific survival: 
HR: 1.10, P=0.776). However, in line with the previous study, 
the hypoxic status did not correlate with treatment response 
in the ESCC group (P=1.00). 
 
Conclusions: Gene expression analysis of the hypoxia 
classifier confirmed that ESCC hold more hypoxic tumors and 
display greater heterogeneity compared to AC. However, 
previous indications that the hypoxia classifier might hold 
prognostic significance in ESCC patients could not be 
confirmed. Ongoing work includes in vitro studies of 
esophageal cancer cell lines in order to identify alternative 
hypoxia induced genes and to further explore the prognostic 
value of hypoxia in patients with loco-regional 
gastroesophageal cancer. 
(1) Winther M et al, Acta Oncol 52(7):1327-35, 2013. 
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Purpose/Objective: In a recent Phase II trial for locally 
advanced prostate cancer we used a narrow margin around 
the prostate clinical target volume (CTV) and prioritized 
rectum sparing when escalating the dose to the prostate, 
seminal vesicles and pelvic lymph nodes by hypo-fractionated 
IMRT. In this study we use patient-specific statistical motion 
modelling to measure the impact of this compromise on the 
actual delivered CTV dose and related it to treatment 
outcome. 
Materials and Methods: The analysis included twelve 
patients with high risk locally-advanced prostate cancer 
treated in the hypo-fractionated protocol, delivering in 25 
fractions 67.5 Gy to the prostate with 2 mm margin 
(PTV67.5), 60 Gy to the prostate and seminal vesicles with 5 
mm margin (PTV60) and 50 Gy to the prostate, seminal 
vesicles and lymph nodes with 10 mm margin (PTV50). Intra-
prostatic gold markers were used for daily image-guidance. 
Rectum sparing (<50 Gy to half the circumference and V60 Gy 
of less than 10 ml) was prioritized. All patients had twice 
weekly repeat CT scans in which all CTVs and OARs were 
contoured. The CTs were aligned on the implanted markers 
simulating the actual treatment. For each patient and each 
segmented structure, contour based deformable registration 
was performed to obtain the vector fields between the organ 
geometry samples acquired at different time points. The 
planned dose distribution and the deformation vector fields 
were subsequently used as input for a principal component 
analysis (PCA). The PCA model was used to perform 
treatment course simulations where for each patient, 10 000 
treatment courses of 25 fractions each were simulated. The 
accumulated D98% for the CTVs and accumulated gEUD with 
volume parameter of 8 and 12 for bladder and rectum, 
respectively were compared to outcome after 6 years of 
follow up. 
Results: 
 
 
The planned dose distributions were robust for CTV50 and 
CTV60 with mean expected D98% of 49.8 Gy and 61.9Gy, 
respectively. For CTV67.5, all twelve patients received a 
systematic lower D98% than planned for (differences ranging 
from -0.4 Gy to -4.5 Gy, with average difference of -2.1 Gy) 
(Figure 1). Five out of these experienced recurrences during 
follow up. The CTV67.5 D98% distribution of the patients with 
recurrence had similar expectation values as the patients 
without recurrence (Figure 1). Only three patients 
experienced Gastro Intestinal (GI) adverse effects. A 
tendency towards outcome distributions with higher expected 
gEUD was seen among these patients (Figure 2). No such 
tendency was seen for the bladder.  
Conclusions: We fournd a considerable intra-patient and 
inter-patient spread in the D98% delivered to the CTV67.5 as 
a consequence of tight margins. Patient-specific dosimetric 
treatment course simulations might be a promising tool in 
dose-volume effect analysis. 
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Purpose/Objective: Anatomical changes occur frequently 
during fractionated radiotherapy of lung cancer patients. As a 
result, the dose to the tumour or organs at risk may deviate 
from the planned dose and become unacceptable. In these 
cases, a new plan should be considered. 
Anatomical changes can be detected with cone-beam (CB) CT 
imaging, but online and offline review are hampered by time 
pressure and workload. In this study we present an automatic 
method to select lung cancer patients eligible for replanning.  
Materials and Methods: An experienced radiation oncologist 
and medical physicist reviewed by consensus CBCTs of 70 
non-small cell lung cancer patients for indications for 
replanning. In case a new plan was made during treatment, 
the CBCT prior to the adaptation was selected. Otherwise, 
the CBCT of fraction 15 was selected. Candidates for 
replanning were selected on anatomical changes in three 
specific regions of interest separately: tumor (PTV), 
mediastinum (MED), and the other tissues (incl. lungs). This 
specifies the number of patients eligible for replanning for 
each specific region.  
Our automatic method is based on differences in density 
between planning CT and CBCT scan for these regions of 
interest. The difference in water equivalent path length 
(WEPL) along 360 degrees (sampled every 1 degree) in each 
transversal plane was calculated. The origin was chosen as 
the centre of the contour in case of the PTV and MED, and at 
the isocenter for the body. The percentage of lines with a 
WEPL difference > 0.5, 1 and 1.5 cm were calculated for the 
PTV and MED. For the body the thresholds were 1, 2 and 3 
cm.  
The obtained values of the patients categorized not eligible 
for replanning, were plotted in 3 dimensions (one threshold 
per axis) for each region of interest. Extreme patients, e.g. 
due to a change in breathing pattern, were excluded. In this 
way an acceptance volume was constructed based on the 
automatic derived thresholds. If a new patient has criteria 
outside the acceptance volume this the patient was flagged 
to be a candidate for replanning.  
The method was evaluated using a leave-one-out strategy. 
The results are expressed as a sensitivity and a false positive 
(FP) rate.  
Results: The sensitivity for the patients flagged for 
replanning was 79%, 71%, and 89% based on anatomical 
change in the PTV, MED, and the other tissues, respectively. 
The FP rate was 27%, 9%, and 19% for these regions, 
respectively. In clinical practice, a flag for one of the regions 
of interest is sufficient to warrant replanning. The overall 
sensitivity is then 89%, with a FP rate of 34%. A common 
reason for FPs was a change in breathing pattern.  
 
 
 
Conclusions: Our method is able to automatically select 
candidates for replanning. For these patients further 
investigation of the dosimetric impact is necessary. The 
method can be further improved by optimization of the 
thresholds, selection of the patients in the learning set, and 
adding features to minimize false positives. 
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Purpose/Objective: In lung cancer radiotherapy, baseline 
shifts (shifts in the mid-ventilation position relative to 
surrounding anatomy) contribute substantially to planning 
margins. For stereotactic primary tumor (PT) treatments, 
these shifts are well studied and often corrected for by 
conebeam CT (CBCT). For patients with involved lymph nodes 
(LN), baseline shifts of these nodes relative to the PT can 
range up to cm’s, so setup is usually based on vertebrae using 
generous margins for both PT and LN. We studied reliable 
automatic determination of baseline shifts in this group and 
an adaptive strategy to reduce planning margins. 
Materials and Methods: For 20 stage III NSCLC patients, 3 
CBCTs were acquired during the first 3 fractions followed by 
5 CBCTs with weekly intervals. First, all CBCTs were rigidly 
registered to the planning CT on nearby vertebrae. For a 
ground truth baseline shift measurement, the PT was 
manually delineated in all 153 CBCTs and the center of mass 
shift of this delineation relative to the planning CT 
determined. For automatic determination of baseline shifts, 
both rigid registration with a mask derived from the planning 
CT PT delineation, as well as whole lung deformable 
registration was applied (Elastix toolkit). Patients were 
classified as ‘movers’ if the average baseline shift in the first 
3 fractions exceeded 3 mm. We examined an adaptive 
strategy: for non-movers it was evaluated if margins could be 
safely reduced. For movers, we investigated if an adapted 
‘average anatomy’ planning scan enabled margin reduction. 
This adapted scan was created from the original planning CT 
using the deformable registration vector fields of the first 3 
CBCTs 
Results: Systematic (Σ) and random (σ) baseline shifts in this 
group were 2-3 mm and 1-2 mm respectively, dependent on 
direction. Both rigid and non-rigid registrations yielded 
baseline shifts to within 1 mm (1 SD) of ground truth values. 
Population planning margins for baseline shifts and residue 
